VistaGen Therapeutics, Inc. (VTGN)
NASDAQ·Healthcare·Biotechnology
$0.26
+12.45%
Mkt Cap $9.89M
Analyst Ratings
No recent rating data.
Price Target (4 analysts)
$0.95
Range $0.90 – $1.00
Implied Upside
+262.6%
Consensus $0.95 vs current $0.26
NASDAQ·Healthcare·Biotechnology
$0.26
+12.45%
Mkt Cap $9.89M
No recent rating data.
Price Target (4 analysts)
$0.95
Range $0.90 – $1.00
+262.6%
Consensus $0.95 vs current $0.26